• Sanofi's BD chief heads to Owkin as CBO; Roche relies on its bench for Thomas Schinecker's diagnostics replacement

    1 month ago - By San Diego Biotechnology

    Alban de La Sablière Up until recently, Alban de La Sablière was Sanofi's chief dealmaker, reporting directly to CEO Paul Hudson without officially being a C-suite executive. That's now changed with de La Sablière's newest...
    Read more ...